GNS.L
Genus plc
Healthcare · LSE · Market cap GBP 1.4bn
2,316p
as of 16 Oct 2026, 28% below its 52-week high
Last paid
Interim
11.2p
+8.7% on the same payment last year.
- Ex-dividend date
- 5 Mar 2026
- Pay date
- 27 Mar 2026
Next dividend
DeclaredFinal
24p
- Ex-dividend date
- 12 Nov 2026
- Pay date
- 4 Dec 2026
Div Impact 1.04%
The payment as a share of today’s price. Shares tend to drop by roughly this much on the ex-dividend date, because buyers from then on no longer get the payment.
- 1-year change
- 0.0%FY2024 to FY2025
- 3-year growth, per year
- 0.0%FY2022 to FY2025
- 5-year growth, per year
- +1.9%FY2020 to FY2025
- 10-year growth, per year
- +5.1%FY2015 to FY2025
- Years without a cut
- 14Last cut in FY2011
- Regular dividends
- Year so far
GNS.L dividends by fiscal year
Totals and changes leave out special dividends.
| Year | Interim | Final | Special | Total | Change |
|---|---|---|---|---|---|
| FY2026 (so far) | 11.2p | 24p | 35.2p | n/a | |
| FY2025 | 10.3p | 21.7p | 32p | 0.0% | |
| FY2024 | 10.3p | 21.7p | 32p | 0.0% | |
| FY2023 | 10.3p | 21.7p | 32p | 0.0% | |
| FY2022 | 10.3p | 21.7p | 32p | 0.0% | |
| FY2021 | 10.3p | 21.7p | 32p | +10.0% | |
| FY2020 | 9.4p | 19.7p | 29.1p | +5.1% | |
| FY2019 | 8.9p | 18.8p | 27.7p | +6.5% | |
| FY2018 | 8.1p | 17.9p | 26p | +10.2% | |
| FY2017 | 7.4p | 16.2p | 23.6p | +10.3% | |
| FY2016 | 6.7p | 14.7p | 21.4p | +9.7% | |
| FY2015 | 6.1p | 13.4p | 19.5p | +10.2% | |
| FY2014 | 5.5p | 12.2p | 17.7p | +9.9% | |
| FY2013 | 5p | 11.1p | 16.1p | +10.3% | |
| FY2012 | 4.5p | 10.1p | 14.6p | n/a | |
| FY2011 | 0p | -100.0%Cut | |||
| FY2010 | 12.1p | 12.1p | +10.0% | ||
| FY2009 | 11p | 11p | +10.0% | ||
| FY2008 | 10p | 10p | +9.9% | ||
| FY2007 | 9.1p | 9.1p | +10.3% | ||
| FY2006 | 8.25p | 8.25p | +10.0% | ||
| FY2005 | 7.5p | 7.5p | +15.4% | ||
| FY2004 | 6.5p | 6.5p | +18.2% | ||
| FY2003 | 5.5p | 5.5p | +15.8% | ||
| FY2002 | 4.75p | 4.75p | n/a | ||
| FY2001 (part year) | 4.5p | 4.5p | n/a |
Amounts are per share as paid, adjusted only for later changes in the number of shares. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.